Average Co-Inventor Count = 7.02
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (26 from 4,179 patents)
2. Galapagos Nv (14 from 116 patents)
3. Abbvie S.a.r.l. (9 from 15 patents)
4. Abbvie Inc. (5 from 822 patents)
5. Abbvie Overseas Sarl (5 from 5 patents)
6. Other (1 from 832,843 patents)
7. Abbvie Global Enterprises Ltd. (1 patent)
46 patents:
1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10604515 - Heteroaryl substituted pyridines and methods of use
7. 10428017 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
8. 10399940 - Substituted pyrrolidines and methods of use
9. 10138227 - Heteroaryl substituted pyridines and methods of use
10. 10118916 - Modulators of cystic fibrosis transmembrane conductance regulator protein
11. 10047051 - Substituted pyridines and method of use
12. 9981910 - Substituted pyrrolidines and methods of use
13. 9840513 - Substituted tricyclics and method of use
14. 9777020 - Furo-3-carboxamide derivatives and methods of use
15. 9642831 - Substituted chromanes and method of use